Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 2776 AL 2790

Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels

Yu-Taeger L, Bonin M, Stricker-Shaver J, Riess O, Nguyen HHP.

Neuropharmacology. 2017 May 1;117:260-272. doi: 10.1016/j.neuropharm.2017.01.029. Epub 2017 Jan 30.

Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview

Ahmad K, Baig MH, Mushtaq G, Kamal MA, Greig NH, Choi I.

Curr Alzheimer Res. 2017;14(11):1190-1197. doi: 10.2174/1567205014666170203141151.

Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease

Velusamy T, Panneerselvam AS, Purushottam M, Anusuyadevi M, Pal PK, Jain S, Essa MM, Guillemin GJ, Kandasamy M.

Oxid Med Cell Longev. 2017;2017:3279061. doi: 10.1155/2017/3279061. Epub 2017 Jan 12.

Hyperkinetic Movement Disorder Emergencies

Cossu G, Colosimo C.

Curr Neurol Neurosci Rep. 2017 Jan;17(1):6. doi: 10.1007/s11910-017-0712-7.

Juvenile Huntington's Disease: Diagnostic and Treatment Considerations for the Psychiatrist

Quigley J.

Curr Psychiatry Rep. 2017 Feb;19(2):9. doi: 10.1007/s11920-017-0759-9.

Targeting the equilibrative nucleoside transporter ENT1 in Huntington disease

Guitart X, Chern Y, Ferré S.

Oncotarget. 2017 Feb 21;8(8):12550-12551. doi: 10.18632/oncotarget.15111.

Post-stroke restless arm syndrome mimicking hemichorea-hemiballism

Kim HY, Park MH, Kwon DY.

Acta Neurol Belg. 2017 Sep;117(3):791-792. doi: 10.1007/s13760-017-0758-y. Epub 2017 Feb 8.

Huntington's disease: of mice and men

Yhnell E.

Oncotarget. 2017 Feb 21;8(8):12552-12553. doi: 10.18632/oncotarget.15129.

Rab7 may be a novel therapeutic target for neurologic diseases as a key regulator in autophagy

Wen H, Zhan L, Chen S, Long L, Xu E.

J Neurosci Res. 2017 Oct;95(10):1993-2004. doi: 10.1002/jnr.24034. Epub 2017 Feb 10.

Classification of involuntary movements in dogs: Paroxysmal dyskinesias

Lowrie M, Garosi L.

Vet J. 2017 Feb;220:65-71. doi: 10.1016/j.tvjl.2016.12.017. Epub 2017 Jan 3.

Contribution of Neuroepigenetics to Huntington's Disease

Francelle L, Lotz C, Outeiro T, Brouillet E, Merienne K.

Front Hum Neurosci. 2017 Jan 30;11:17. doi: 10.3389/fnhum.2017.00017. eCollection 2017.

Molecular Imaging Markers to Track Huntington's Disease Pathology

Wilson H, De Micco R, Niccolini F, Politis M.

Front Neurol. 2017 Jan 30;8:11. doi: 10.3389/fneur.2017.00011. eCollection 2017.

GNAO1-associated epileptic encephalopathy and movement disorders: c.607G>A variant represents a probable mutation hotspot with a distinct phenotype

Arya R, Spaeth C, Gilbert DL, Leach JL, Holland KD.

Epileptic Disord. 2017 Mar 1;19(1):67-75. doi: 10.1684/epd.2017.0888.

High bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation

Ullah F, Liang A, Rangel A, Gyengesi E, Niedermayer G, Münch G.

Arch Toxicol. 2017 Apr;91(4):1623-1634. doi: 10.1007/s00204-017-1939-4. Epub 2017 Feb 15.

Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations

Bading H.

J Exp Med. 2017 Mar 6;214(3):569-578. doi: 10.1084/jem.20161673. Epub 2017 Feb 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias